Comparative Study of Fluconazole and Clotrimazole in the Treatment of Vulvovaginal Candidiasis
Authors:
- Sharon ChristensenSCSharon Christensen
- Nancy MummawNMNancy Mummaw
- 1 June 1991
- journal article
- clinical trial
- Published by SAGE Publications in DICP
- Vol. 25 (6) , 582-585
Abstract
Fluconazole is a new oral triazole antifungal with good activity against Candida spp. In this study, we investigated the effectiveness and tolerability of a three-day course of treatment with fluconazole compared with clotrimazole vaginal tablets in nonpregnant women with acute Candida vaginitis. Of the 90 evaluable patients who received fluconazole, 76 (84 percent) were asymptomatic seven to ten days after treatment compared with 84 of 95 (88 percent) treated with clotrimazole. An additional ten patients in the fluconazole group (11 percent) and seven in the clotrimazole group (7 percent) had improvement in their signs and symptoms. Only four patients in each group (4 percent) were considered treatment failures. Mycological cures were obtained in 89 and 93 percent of patients treated with fluconazole and clotrimazole, respectively, seven to ten days posttreatment. Clinical cure rates remained high one month posttreatment: 79 percent in the fluconazole group and 83 percent in the clotrimazole group. Both therapies were well tolerated. One patient discontinued treatment after she developed diarrhea while receiving fluconazole. The most common adverse effects associated with fluconazole use were nausea (six percent) and diarrhea (three percent). No clinically significant laboratory abnormalities were observed. In this investigation, oral fluconazole therapy was found to be as safe and effective as clotrimazole vaginal tablets in women with acute vulvovaginal candidiasis.Keywords
This publication has 14 references indexed in Scilit:
- Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasisAntimicrobial Agents and Chemotherapy, 1990
- Pharmacokinetics and Tissue Penetration of Fluconazole in HumansClinical Infectious Diseases, 1990
- Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic ratsAntimicrobial Agents and Chemotherapy, 1989
- A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trialEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1988
- Single-Dose Oral Fluconazole in the Treatment of Vaginal CandidosisAnnals of the New York Academy of Sciences, 1988
- Treatment of vaginal candidiasis with a single oral dose of fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Overview of medically important antifungal azole derivativesClinical Microbiology Reviews, 1988
- Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitroJournal of Antimicrobial Chemotherapy, 1986
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Ketoconazole in Vulvovaginal CandidosisClinical Infectious Diseases, 1980